Literature DB >> 142009

Primary structure of the B-chain of human plasmin.

B Wiman.   

Abstract

The primary structure of the human plasmin B-chain has been determined. It consists of 230 residues divided in three cyanogen bromide fragments: The amino-terminal 24 residues, the carboxy-terminal three residues and the middle 203 residues. Sequence detemination was performed on the tryptic and the chymotryptic peptides obtained from the main cyanogen bromide fragment of this chain. Owing to similarities between some of the overlapping chymotryptic peptides, two different sequences were possible from these results. However, since the homologies with the pancreatic serine proteases and also the B-chains of thrombin and factor XA are pronounced, the arrangement still could be settled. By peptic digestion of partially reduced and S-carboxymethylated B-chain it was shown that there are two interchain disulphide bridges, which connect the A and B-chains of plasmin, involving Cys-5 and Cys-105 from the B-chain. The intrachain disulphides in the B-chain seem to be situated exactly as in chymotrypsin as partly judged from homologies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142009     DOI: 10.1111/j.1432-1033.1977.tb11578.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

Review 1.  The human plasma fibrinolytic system: regulation and control.

Authors:  K C Robbins
Journal:  Mol Cell Biochem       Date:  1978-08-16       Impact factor: 3.396

2.  Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis.

Authors:  A Ichinose; E S Espling; J Takamatsu; H Saito; K Shinmyozu; I Maruyama; T E Petersen; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

3.  Quantitative differences in specific binding of fibrinogen fragment D by M-positive and M-negative group-A streptococci.

Authors:  K H Schmidt; D Gerlach; O Kühnemund; W Köhler
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

4.  Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.

Authors:  S Müllertz; S Thorsen; L Sottrup-Jensen
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

5.  Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site.

Authors:  T Miyata; S Iwanaga; Y Sakata; N Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

Review 6.  Biochemistry of the plasmin system.

Authors:  D Ogston
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

7.  The influence of the nature of the asparagine 289-linked oligosaccharide on the activation by urokinase and lysine binding properties of natural and recombinant human plasminogens.

Authors:  D J Davidson; F J Castellino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase.

Authors:  T Urano; B A Chibber; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.

Authors:  Jeilyn Vivas; Carlos Ibarra; Ana M Salazar; Ana G C Neves-Ferreira; Elda E Sánchez; Jonás Perales; Alexis Rodríguez-Acosta; Belsy Guerrero
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-28       Impact factor: 3.228

10.  Structural/functional properties of the Glu1-HSer57 N-terminal fragment of human plasminogen: conformational characterization and interaction with kringle domains.

Authors:  S S An; D N Marti; C Carreño; F Albericio; J Schaller; M Llinas
Journal:  Protein Sci       Date:  1998-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.